Electrical conductivity and thermodynamic studies on Sodium Dimethyldithiocarbamate in non aqueous solvents Dimethylformamide (DMF), at different temperatures.

This paper threw some light on the behavior of Sodium N,N-Dimethyldithiocarbamate as an electrolyte. The effect of solvents on the conductance of this salt would be discussed via measurements of Λo, ao and KA, since it can be assumed that the different solvents have a little chance to impose great variations on the solvation processes. The conductance method was chosen as a tool to illustrate the electrolyte-solvent interactions. Fuoss-Onsager equation would be tested using Sodium Dimethyldithiocarbamate in presence of dimethylformamide solvent at different temperatures. The conductance of dilute solutions of Sodium N,N-Dimethyldithiocarbamate is measured in Dimethylformamide, at different temperatures (25, 30, 35 and 40 °C). Accurate values of Λo were obtained by applying the (Fuoss-Kraus-Shedlovsky) equation. Finally, the (Fuoss-Onsager) equation was solved to give the correct values of the constants Λo, J, KA and a° (the closest distance of approach) for Sodium N,N-Dimethyldithiocarbamate salt in Dimethylformamide solvent. Λo and a° (solvation) increase with increasing temperatures. Thermodynamic parameters (∆G°, ∆H°, ∆S° and ∆Es) of Sodium N,N-Dimethyldithiocarbamate in Dimethylformamide were calculated from conductance measurements, the activation energy (∆Es), the enthalpy change (heat of association) (∆H°) and the entropy change (∆S°) are positive, however The free energy change (∆G°) values was negative for Sodium N,N-Dimethyl dithiocarbamate in DMF systems studied with increasing the temperature.

A unique, inexpensive, and abundantly available adsorbent: composite of synthesized silver nanoparticles (AgNPs) and banana leaves powder (BLP).

The purpose of this study is to investigate the development of a new and inexpensive adsorbent by immobilization synthesized silver nanoparticles (AgNPs) onto banana leaves powder (BLP), and the prepared composite (BLP)/(AgNPs) was used as an adsorbent for Zn(II), Pb(II), and Fe(III) ion removal from aqueous solutions under the influence of various reaction conditions. (BLP)/(AgNPs) demonstrated remarkable sensitivity toward Zn (II), Pb (II), and Fe (III) ions; metal ions eliminations increased with increasing contact time, agitation speed, adsorbent dose, and temperature, yielding adequate selectivity and ideal removal efficiency of 79%, 88%, and 91% for Zn (II), Pb (II), and Fe (III) ions, respectively, at pH = 5 for Zn(II) and pH = 6 for Pb(II), and Fe(III). The equilibrium contact time for elimination of Zn (II), Pb (II), and Fe (III) ions was reaches at 40 min. Langmuir, Freundlich, and Temkin equations were used to test the obtained experimental data. Langmuir isotherm model was found to be more accurate in representing the data of Zn(II), Pb(II), and Fe(III) ions adsorption onto (BLP)/(AgNPs), with a regression coefficient (R2 = 0.999) and maximum adsorption capacities of 190, 244, and 228 mg/g for Zn(II), Pb(II), and Fe(III) ions, respectively. The thermodynamic parameters proved that adsorption of metal ions is spontaneous, feasible, and endothermic, whereas Kinetic studies revealed that the process was best described by a pseudo second order kinetics.

Effects of oral contraception on liver function tests and serum proteins in women with past viral hepatitis.

Forty-three women who had viral hepatitis one or more years ago and 35 healthy women who were age and parity matched were given an oral contraceptive containing 0.05mg ethinyl estradiol and 0.5mg levonorgestrel for six consecutive months. Liver function tests (serum bilirubin, SGOT, SGPT and serum alkaline phosphatase) and serum proteins (total, albumin, globulins, ceruloplasmin, haptoglobin and alpha-1 antitrypsin) were measured before beginning treatment and after three and six months of use. Past hepatitis women experienced increased unconjugated bilirubin, SGOT, SGPT and alkaline phosphatase levels throughout the six months while the control women showed less pronounced changes during the first three months with tendency to reversion to normal during the subsequent three months; the group X time of test interactions were significantly different between the two groups. Serum haptoglobin decreased significantly in both groups but the past-hepatitis group showed a more persistent change with time. Changes also occurred in serum albumin, alpha-1 and beta globulins, ceruloplasmin but without group effect or group X time interactions.

Effects of oral contraception on liver function tests and serum proteins in women with active schistosomiasis.

Thirty-eight women with urinary or intestinal schistosomiasis but without clinical or laboratory evidence of hepatic involvement and 30 healthy control women were treated with an oral contraceptive containing 0.05mg ethinyl estradiol and 0.05mg levonorgestrel for six consecutive months. Liver function tests (serum bilirubin, SGOT, SGPT, serum alkaline phosphatase) and serum proteins (total, albumin, globulins, ceruloplasmin, haptoglobin and alpha-1 antitrypsin) were measured before beginning the treatment and after three and six months of use. Both group experienced significant increases in SGOT, SGPT and serum alkaline phosphatase during the first three months of treatment with tendencies to decrease during the subsequent 3 months. No change occurred in serum bilirubin. There was significant decreases in serum albumin and haptoglobin and increases in alpha-1 globulin, ceruloplasmin and alpha-1 globulin, there were no significant differences between schistosomiasis patients and the controls in terms of changes in any laboratory test as a result of the treatment, thus suggesting that patients with active schistosomiasis do not incur a higher risk of hepatic dysfunction while using oral contraception.

Sex steroids in women with liver cirrhosis.

Eighteen women with hepatic cirrhosis were examined for plasma levels of testosterone, estrone, estradiol, progesterone and sex hormone binding globulin. For eight who were amenorrheic, with advanced liver cirrhosis and ascites, the reduction of testosterone and rise in estrone and sex hormone binding globulin concentrations were significant. Plasma extradiol and progesterone were lower than normal levels, but the differences were not statistically significant. The other ten patients were menstruating (mostly irregularly), and their hormonal levels were assessed in different states of their cycles. All of them did not ovulate, had low levels of plasma progesterone and also showed consistent estrone concentration excess relative to estradiol and significant lowering of testosterone and elevation of sex hormone binding globulin. These findings are compared with previous reports on males with liver cirrhosis.